Search Results

Press Releases

Asahi Kasei Establishes Asahi Kasei Life Science to Drive its Bioprocess Businesses Forward

April 9, 2025

·

3 min read

Press Releases

Chris Rombach appointed President of Asahi Kasei Bioprocess America

February 19, 2025

·

4 min read

Pharm Country

Asahi Kasei Launches Membrane System to Produce Water for Injection

Asahi Kasei has announced that in April 2024 it began selling a membrane system to produce WFI, a type of sterile water that is used for the preparation of injections.

June 13, 2024

·

3 min read

Deals

Asahi Kasei to Acquire Calliditas Therapeutics AB to Accelerate Growth as a Global Healthcare Company

Asahi Kasei Corp. announces that it will offer the shareholders of Calliditas Therapeutics AB to acquire the shares of the pharmaceutical company Calliditas for the purpose of making Calliditas a wholly-owned subsidiary of Asahi Kasei through a voluntary tender offer for Calliditas.

May 28, 2024

·

7 min read

Business

Asahi Kasei starts operation of multi-module hydrogen pilot plant in Kawasaki

The Japanese technology company Asahi Kasei is further accelerating its hydrogen business activities.

May 14, 2024

·

5 min read

Business

Asahi Kasei Bioprocess and Axolabs Announce Strategic Partnership to Accelerate Oligonucleotide Therapeutics Development

Asahi Kasei Bioprocess (AKB), part of the Asahi Kasei Group, and Axolabs have announced a strategic partnership in the burgeoning field of oligonucleotide therapeutics.

April 11, 2024

·

5 min read

Business

Asahi Kasei Medical and AW Technologies enter exclusive distribution agreement for TrachFlush in Japan

AW Technologies and Asahi Kasei Medical, a core operating company of the Asahi Kasei Group, have entered into an exclusive distribution agreement in Japan for AW Technologies’ TrachFlush™ device.

April 3, 2024

·

3 min read

Deals

Statement by the Board of Directors of Calliditas Therapeutics AB (publ) in relation to the public offer by Asahi Kasei Corporation

The Board of Directors of Calliditas Therapeutics AB unanimously recommends that the shareholders and holders of American Depositary Shares of Calliditas Therapeutics AB accept the public tender offer by Asahi Kasei Corporation.

May 28, 2024

·

24 min read

Pharm Country

Crystal IS and Asahi Kasei have achieved 99% usable area on 100 mm bulk aluminum nitride substrate

Crystal IS, an Asahi Kasei company, announced the successful serial production of 100 mm diameter single-crystal aluminum nitride substrates with 99% usable area, based on current requirements for UVC LEDs, with manufacturing to take place in the United States.

June 12, 2024

·

3 min read

Press Releases

Asahi Kasei Pharma Strengthens Global Reach with Exclusive License Agreement for anti-CX3CR1 Antibody

December 11, 2024

·

3 min read